http://www.oxford-instruments.com/Pages/home.aspx


Oxford Instruments is a leading provider of high technology tools and systems for research and industry. We design and manufacture equipment that can fabricate, analyse and manipulate matter at the atomic and molecular level.

Oxford Instruments has discrete business groups operating in three sectors. This means we can focus our expertise, our technologies and our innovation on offering our customers high quality products and service that meet their stringent requirements.







Financial Calendar


Half Year/Interim Results Announcement

Tuesday November 13th 2012 : 9.30am The London Stock Exchange

Annual General Meeting:

Tuesday 11th September 2012 : 2.30pm

Oxford Instruments plc, Tubney Woods, Abingdon, Oxon OX13 4QX

26 September 2012 Ordinary shares quoted ex-dividend
28 September 2012 Record date for final dividend
30 September 2012 DRIP date
25 October 2012 Payment of final dividend
March 2013 Ordinary shares quoted ex-dividend
Dividend reinvestment (DRIP) last date for election
Record date for interim dividend
31 March 2013 Financial Year End

In IC this week- slow going at Oxford instruments.

Oxford instruments has stacks of long -term potential, but with down-grades likely and growth uncertain, the shares rate no more than a hold.

Black Rock add http://www.moneyam.com/action/news/showArticle?id=4614971

18 Jun Investec 1,490.00 Hold

24 Jun N+1 Singer 1,390.00 Hold

Like just about everything else D/C.. on the slide, will be worth buying at some point though.

Kames Capital go below 4%

Oxford Instruments: Goldman Sachs cuts target price from 2100p to 1850p, while keeping its buy recommendation.

Interim Management Statement

RNS


RNS Number : 1623J

Oxford Instruments PLC

12 July 2013






Release date: 12 July 2013

Oxford Instruments plc

Interim Management Statement

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today issues an Interim Management Statement which covers the period from 1 April 2013 to date.

As discussed in our Preliminary Statement, the year started slowly with performance in the first two months of the year down against a very strong comparative period in the prior year. However, in the third month of the quarter, orders, sales and profits were much improved compared to each of the first two months and were also ahead of the same period in 2012/13. Average monthly order intake in the quarter was above the monthly average for the last financial year in Asia by 18% but below in North America by 20% and in Europe by 1%.

Our broad spread of geographies and technologies and our strong pipeline of new products continue to underpin the long term prospects for the Group. The Board anticipates that Oxford Instruments will continue to make progress in line with its expectations for the remainder of the financial year and remains focused on achieving its 14 Cubed objectives.

On 11th June 2013 Jennifer Allerton joined the board as an Independent Non-Executive Director.



Save as described in this statement, there has been no significant change in the financial position of the Group in the period.



- Ends -

12 Jul N+1 Singer 1,390.00 Hold

Oxford Instruments reports slow start to the year

Fri, 12 July 2013



Chg %: 9.60%

Date: 16:41


Oxford Instruments, which provides technology for research, had a slow start to the year but sales have picked up, according to a trading update for April 1st to date.

The company said performance in the first two months of the year was down in comparison to a strong prior year. However, sales and profits improved in the third month of the quarter, ahead of the same period last year.

Average monthly order intake in the quarter was higher than the last financial year in Asia by 18% but below in North America by 20% and in Europe by 1.0%.

“Our broad spread of geographies and technologies and our strong pipeline of new products continue to underpin the long term prospects for the group,” the company said.

“The board anticipates that Oxford Instruments will continue to make progress in line with its expectations for the remainder of the financial year and remains focused on achieving its 14 Cubed objectives.”

15 Jul Jefferies... 1,420.00 Hold
15 Jul JP Morgan... 1,750.00 Overweight

Kames Capital go below 3%

Oxford Instruments: Numis downgrades to add with a target price of 1600p

AGM Statement

RNS


RNS Number : 5749N

Oxford Instruments PLC

10 September 2013






Oxford Instruments plc

Chairman's AGM Statement 2013



Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, is holding its annual general meeting today in which the Chairman, Nigel Keen will make the following statement:



"In June 2011 we outlined our 14 Cubed objective to achieve a compound annual revenue growth rate of 14% and a return on sales of 14% by the financial year ending March 2014. It was anticipated that this objective would be achieved predominantly through organic growth and continuing internal efficiency improvements, augmented by targeted acquisitions.



The year to March 2013 was the second year of the 14 Cubed plan and we saw compound revenue growth of 15.6% over the two years with return on sales last year of 14.2%.



In the current year, average monthly orders in our Nanotechnology Tools sector are ahead of last year in Asia but are behind in North America and Europe as government agencies in these territories examine their spending on Research and Development. We believe this is particularly true in the USA where the uncertainty caused by budget sequestration has caused orders to be delayed. Asylum Technology, which we acquired in December 2012, is performing well, with results in line with expectations.



Our Industrial Products sector has seen growth in average monthly orders over the previous year in Asia and Europe as global economies begin to recover. North America is still down on the prior year but the trend is improving.



Our third party service business is performing well with the recently acquired Platinum Medical Imaging business continuing to gain traction and delivering the integration benefits.



Outlook

The growth in the order intake rate in Industrial Products and third party Service is encouraging but the slowness in R&D markets in the Western economies means that the year is likely to be more second half weighted than has been seen in recent periods. This will be aided by the continuing recovery in trading conditions in North America

The Capital Group Companies, Inc. go above 16% http://www.moneyam.com/action/news/showArticle?id=4667837

18 Sep Investec 1,515.00 Hold

Black Rock Inc. Go below 18% http://www.moneyam.com/action/news/showArticle?id=4690166

Interim's out tomorrow, wonder how much the foreign exchange rates are affecting these.

Stan, this was in Shares this week -The company designs and supplies some of the very high-technology tools and systems that scientists and researchers need to develop advanced applications. Its business model sees high-tech equipment sold into nanotechnology and industrial markets across the globe, and increasingly to Far East markets keen to expand their technological and scientific research base. This provides a vast and growing installed base from which after-sales parts and service revenues stem, generating highly visible and rising revenues. The company prides itself on turning smart science and innovation into commercially successful products, raising the barriers to entry for new competitors. Research spending cuts in Europe and the US have temporarily slammed the brakes on yet Oxford insists it remains on target to match its ’14 Cubed’ objectives (14% average revenue growth and return on sales, by 2014) (see The Big Debate, pages 36-37). Analysts at Numis point out: ‘Demand for Oxford’s products is being driven by the shift to smaller applications and the ability to analyse and manipulate matter at the atomic level.’ That means increasing nanotechnology research paid for with bigger and bigger budgets, in time. Numis estimates funding levels will increase between 10% and 20% a year going forward, underpinning EPS estimates it has for Oxford of 75.6p next year to March 2015, and 84.2p the year after. That implies a PE of 17.3 falling to 15.

Thanks for that DC, we will know tomorrow.